Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference48 articles.
1. The Biology of Chronic Myeloid Leukemia
2. The molecular biology of chronic myeloid leukemia
3. Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
4. Imatinib: a selective tyrosine kinase inhibitor
5. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics;Biomarker Research;2024-08-21
2. Degraders upgraded: the rise of PROTACs in hematological malignancies;Blood;2024-03-28
3. Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review;International Journal of Molecular Sciences;2024-01-05
4. BCR/ABL1ΔE7‐8‐9 isoform contributes to tyrosine kinase inhibitor resistance in chronic myeloid leukemia;Hematological Oncology;2022-06-17
5. Competing endogenous RNA regulation in hematologic malignancies;Clinica Chimica Acta;2020-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3